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Abstract
Insulin regulates ovarian phosphatidylinositol-3-kinase (PI3K) signaling, important for primordial
follicle viability and growth activation. This study investigated diet-induced obesity impacts on: 1)
insulin receptor (Insr) and insulin receptor substrate 1 (Irs1); 2) PI3K components (Kit ligand
(Kitlg), kit (c-Kit), protein kinase B alpha (Akt1) and forkhead transcription factor subfamily 3
(Foxo3a)); 3) xenobiotic biotransformation (microsomal epoxide hydrolase (Ephx1), Cytochrome
P450 isoform 2E1 (Cyp2e1), Glutathione S-transferase (Gst) isoforms mu (Gstm) and pi (Gstp))
and 4) microRNA’s 184, 205, 103 and 21 gene expression. INSR, GSTM and GSTP protein levels
were also measured. Obese mouse ovaries had decreased Irs1, Foxo3a, Cyp2e1, MiR-103, and
MiR-21 but increased Kitlg, Akt1, and miR-184 levels relative to lean littermates. These results
support that diet-induced obesity potentially impairs ovarian function through aberrant gene
expression.
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1. Introduction
Globally, the prevalence of overweight and obesity is increasing, predisposing female to
health hazards including diabetes, cardiovascular disease, cancer and compromised
reproductive capacity [1-4]. 1.5 billion adults are overweight of whom 200 million men and
300 million women are obese. Further, approximately 43 million children (age 5-19) are
overweight [5-10]. About 65% of the world’s population live in countries where being
overweight is more responsible for morbidity than underweight, and currently about 2.8
million adults globally die every year as a result of being overweight or obese [1]. Formerly
considered a problem of developed countries, this epidemic is now dramatically on the rise
in low- and middle-income countries which have had a long incidence of food insecurity,
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now squaring them up for a binary affliction of disease. While toiling with infectious disease
and under-nutrition, they are also paradoxically experiencing a rapid upsurge in non-
communicable disease risk factors including obesity and overweight [11-13].
The mammalian ovary is the female gonad responsible for gamete production, as well as the
female sex steroids, 17β-estradiol and progesterone. The ovary contains a finite number of
primordial follicles at the time of birth, which serve as the follicular pool. Once depleted,
primordial follicles cannot be replaced [14-22]. Though this theory has been to a certain
extent challenged in recent years [23-25], it remains that the number of primordial follicles
declines over the female lifetime. This is because the process of follicular growth is an
irreversible process; once follicles are recruited from the resting pool into the growing pool
they will undergo cell death if not selected for further growth to ovulation [26-33]. Unlike
the cyclic recruitment of follicles to ovulation, initial follicular activation is independent of
the pituitary gonadotropins [17, 18, 34, 35]. The intrinsic ovarian mechanism(s) triggering
individual follicle activation are not yet fully known, however, several lines of evidence
have identified potential candidate factors including phosphatidylinositol-3 kinase (PI3K).
An overall balance among dormancy, activation and death of primordial follicles is believed
to be the determining factor which decides the female reproductive lifespan [29, 31, 36-38].
Any external factor that could accelerate follicle activation could hasten the rate at which the
ovary become devoid of the follicular pool, thus threatening the reproductive potential of the
female.
Obesity has been demonstrated to have detrimental effects on female reproductive function.
Obese women have an increased likelihood to display signs of polycystic ovarian syndrome
(PCOS), ovulation defects, reduced fecundity and poor quality oocytes [4, 39, 40]. There is
also an association between obesity and an increased risk of birth defects, premature and
still-births, and gestational diabetes [4, 41], however, the molecular mechanisms involved
are still lacking. Obesity is a contributing factor for development of type 2 diabetics,
characterized by elevated blood glucose and impaired insulin signaling [42]. Diet-induced
obesity with concomitant diabetes is a stimulus that provokes alterations in insulin level and
its subsequent sensitivity on its target tissues. It has been long postulated that obesity not
only compromises insulin sensitivity in classical tissues like muscle and liver but also in
other insulin responsive tissues like the ovary [42-44]. This theory has recently been
challenged in a diet-induced obesity model, where ovaries from female mice fed on 60 %
kcal of fat for 12 weeks maintained insulin sensitivity, despite that other classical tissues like
muscle and liver became insulin resistant [45].
The ovary possesses both insulin and insulin-like growth factor 1 (IGF-1) receptors which
can be directly stimulated by their hormone ligands. Insulin not only controls critical energy
functions such as glucose and lipid metabolism but also plays a crucial role in reproductive
function. Insulin receptor (INSR) is a heterodimer comprised of two alpha subunits and two
beta subunits [46, 47]. Insulin binds to the alpha subunits which activates the insulin
receptor tyrosine kinase in the beta subunits, with subsequent auto phosphorylation and
recruitment of different substrate adaptors such as the Insulin receptor substrate (IRS 1-4)
family of proteins. Tyrosine phosphorylated IRS then display binding sites for numerous
signaling partners including the PI3K/Protein kinase B (PKB/AKT) signaling pathway.
Defects in IRS, more specifically IRS1 and IRS2, have been implicated in female infertility
and rodent models with such defects have been found to display both ovarian and
hypothalamic dysfunction [48-50].
Several lines of evidence have identified the importance of PI3K signaling in ovarian
function [51]. Once PI3K is activated, AKT is recruited to the cell membrane where it
becomes phosphorylated (pAKT), and mediates many downstream events [52-54]. PI3K/
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AKT has been implicated in regulating follicular activation [36, 38] recruitment, survival
[29, 31], and development throughout the female reproductive lifespan [31, 51, 55-57]. PI3K
also plays a role in proliferation and differentiation of granulosa cells (GC) in response to
gonadotropins [29, 58] and it has been associated with ovarian carcinoma [31, 37, 38, 51,
55, 57-60]. In rodent models, Akt−/− mice were found to have reduced primordial follicle
viability [57]. AKT has the ability to phosphorylate and inactivate several targets including
forkhead transcription factors (FoxO). FoxO3 is critical for early stages of follicular growth
[55] and it has been reported to trigger apoptosis through either up-regulation of genes
necessary for cell death or down-regulation of anti-apoptotic genes [61-64]. FOXO3−/− mice
had global primordial follicle activation by postnatal day 14, leading to oocyte death, early
depletion of functional ovarian follicles and secondary infertility [55] while in FOXO3OE
mice, no activation of primordial follicle pool was observed [65].
Insulin-mediated PI3K activation has been also suggested to regulate xenobiotic
biotransformation genes [66]. Inhibition of ovarian PI3K increases both mRNA and protein
levels of microsomal epoxide hydrolase (Ephx1)[67] Glutathione S-transferase Pi (Gstp)
[68] and Glutathione S-transferase Mu 1 (Gstm) [69] suggesting that these enzymes could be
downstream members of the PI3K signaling pathway. GSTP and GSTM are members of the
GST protein family involved in phase II metabolism of xenobiotic compounds by converting
a variety of electrophilic and hydrophobic compounds into more soluble, easily excretable
compounds through catalyzing their conjunction with glutathione (GSH) [70]. EPHX1 and
Cytochrome P450 isoform 2E1 (CYP 2E1) ensure the rapid detoxification of epoxides
generated during the oxidative metabolism of xenobiotics, thus providing cellular protection
against free radical and carcinogenic compounds [66, 71-73]. Any alteration in expression
patterns of genes that encode for ovarian chemical biotranformation enzymes can pose a risk
for the onset of ovarian dysfunction. This is because exposure to a number of chemical
classes can destroy follicles of all types threatening the reproductive potential of exposed
females through accelerated premature ovarian insufficiency, premature ovarian failure
(menopause) and other associated health problems [22, 67, 74-77].
Several genes that are components of the PI3K pathway also are regulated by MicroRNAs
(miR’s) [78-80]. MiR’s are small (19 – 25 bp) non-coding RNA that can positively or
negatively regulate gene expression [81-85]. It is known that miR-21 inhibits phosphatase
and tensin homolog (PTEN), an antagonist of PI3K [86, 87]. In vivo loss of miR-21 has
been reported to increase ovarian apoptosis and as well compromise ovulation rates in
rodent models [86, 88]. MiR-184 is believed to play a critical role in development as well as
a mediator of apoptosis [79]. Up regulation of miR-184 can interfere with AKT action,
repressing PI3K action [78, 85]. Also, miR-103 has been implicated in insulin sensitivity
[89]. Thus, miR’s may mediate the response to insulin signaling, through the PI3K pathway.
In summary, obesity results in reproductive dysfunction and an increase in negative
consequences for offspring, and insulin signaling is impaired in obesity. Additionally,
insulin can activate PI3K signaling, which is critical for controlling the rate of activation of
primordial follicles, and is an upstream regulator of xenobiotic metabolism gene expression.
There remains a dearth of knowledge regarding whether obesity can influence ovarian
xenobiotic metabolism, thus we hypothesized that obesity caused by a high fat diet would
alter ovarian PI3 kinase signaling with subsequent effects on genes encoding xenobiotic
metabolism enzymes in female mice.
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2. Materials and Methods
2.1. Reagents
2-β-mercaptoethanol, 30% acrylamide/0.8% bis-acrylamide, ammonium persulfate, glycerol,
N’,N’,N’,N’-Tetramethyl-ethylenediamine (TEMED), Tris base, Tris HCl, sodium chloride,
Tween-20, bovine serum albumin (BSA), ascorbic acid (Vitamin C), phosphatase inhibitor,
protease inhibitor and transferrin were purchased from Sigma-Aldrich Inc. (St. Louis, MO).
Hanks’ Balanced Salt Solution (without CaCl2, MgCl2, or MgSO4), DAPI nuclear stain and
superscript III one-step RT-PCR System were obtained from Invitrogen Co. (Carlsbad, CA).
miRNeasy Mini Kit, miScrip Reverse Transcription Kit, miScrip SYBR Green PCR Kit,
RNeasy Mini kit, QIAshredder kit, RNeasy MinElute kit, TaqMan® microRNA Reverse
Transcription Kit and QuantitectTM SYBR Green PCR kit were purchased from Qiagen Inc.
(Valencia, CA). Goat anti-rabbit and goat anti-mouse secondary antibodies were purchased
from Pierce Biotechnology (Rockford, IL). Custom designed primers were obtained from
the DNA facility of the Office of Biotechnology at Iowa State University. Ponceau S was
purchased from Fisher Scientific (Waltham, MA, USA). ECL plus chemiluminescence
detection kit was obtained from GE Healthcare, Amersham (Buckinghamshire, UK). Anti-
GSTP and anti-GSTM antibodies were purchased from Millipore (Temecula, CA, USA).
Anti-pAKTSer473 and β-Actin antibodies were from Cell Signaling Technology and anti-
insulin receptor (INSR) antibody was purchased from Abcam (Cambridge, MA, USA).
Secondary antibodies were obtained from EMD Millipore (Billerica, MA).
2.2. Animal and diets
Ovarian tissues were obtained from a study at the University of Missouri. The experimental
protocols were approved and performed in accordance with the guidelines of the University
of Missouri Institutional Animal Care and Use committee as previously described [90].
Briefly, twelve 6 weeks old C57Bl/6J female mice were randomized into two groups (n = 6
per group). The control group was fed a standard chow mice diet (Purina 5001; 4.5g/100g
fat) while the treatment group was fed a high-fat diet (HFD; Research Diets D12492; 35g/
100g fat) for approximately 7 months. The animals were housed at constant room
temperature, 12h light:12h darkness cycle, diet and water were provided ad libitum. Body
weight for the control and HFD mice were 24.8g ± 0.45 and 46.5g ± 2.0, respectively.
Gonadal adipose tissue weight was 0.44g ± 0.05 and 3.74g ± 0.35 in the control and HFD
mice, respectively [90]. After 7 months glucose tolerance testing confirmed that HFD-fed
mice had elevated blood glucose, relative to their control-diet fed littermates [90]. There was
no impact of HFD on plasma estradiol [90]. The HFD mice are subsequently referred to as
obese, and their non-HFD fed littermates are referred to as lean.
2.3. Tissue collection
Animals were euthanized by CO2 asphyxiation. Ovaries were removed, trimmed of excess
fat, weighed and snap frozen for gene expression analysis or fixed in 4% paraformaldehyde
for histological analysis.
2.4. RNA Isolation
Total ovarian RNA was isolated using Qiagen RNeasy® Mini Kit (n = 6 per dietary
treatment). Briefly, ovaries were lysed and homogenized using a hand held homogenizer.
The homogenate was then applied to a QIAshredder column placed in a collection tube and
centrifuged at 16100 RCF for 2 minutes at room temperature. The flow through was then
applied to an RNeasy Mini column, allowing RNA to bind to the filter cartridge. Following
washing, RNA was eluted from the filter and concentrated using an RNeasy MinElute kit.
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RNA was eluted using 14 μl of RNase-free water and quantified using an ND-1000
Spectrophotometer (λ = 260/280 nm; NanoDrop technologies, Inc., Wilmington, DE).
2.5. First Strand cDNA synthesis and quantitative Real-Time quantitative polymerase chain
reaction (qRT-PCR)
Total RNA (0.5 μg) was reverse transcribed to cDNA using Invitrogen™ Superscript III
Reverse Transcriptase according to the manufacturer’s protocol. Diluted cDNA (2 μl; 1:20
dilution) were amplified on an Eppendorf Mastercycler using Quantitect™ SYBR Green
PCR kit and primers specific for mouse Actb, Insr, Irs1, Kit Ligand (Kitlg), c-Kit, Akt1,
Foxo3a, Cyp2e1, Ephx1, Gstp, and Gstm (See table 1 for primer sequences). The PCR
cycling program consisted of a 15 min hold at 95 °C and 40 cycles of: denaturing for 15 at
95 °C, annealing for 15s at 58 °C and extension at 72 °C for 20s. Product melt conditions
were determined using a temperature gradient from 72 °C to 99 °C with a 1 °C increase at
each step. Three replicates of each sample (n = 6 per dietary treatment) were included.
Statistical analysis was performed on the cycle numbers at which each sample reached a
threshold level. The relative mRNA expression for each of the above genes was normalized
using mouse Actb as a housekeeping gene and relative fold change calculated using the
2−ΔΔCT method. The results are presented as mean fold change ± standard error relative to
the control group.
2.6. mirScript miRNA PCR array
Purification of miRNA-enriched fractions was performed using a miRNeasy Mini Kit
according to manufacturer’s protocol (n = 3 per dietary treatment). MiRNA-enriched
fractions (250 ng) in a reverse-transcription reaction of 20 μl were converted to cDNA using
miScrip Reverse Transcription Kit. cDNA was then diluted by adding 200 μl of RNase-free
water, from which, 100 μl was used as template cDNA for real-time PCR quantification of
multiple microRNAs using miScrip SYBR Green PCR Kit. Data analysis was performed
using the web-based miScript miRNA PCR Array Data Analysis package. TaqMan®
microRNA Reverse Transcription Kit was used to validate the expression of miR-21. The
amount of target miRNA was normalized using RNU43 as a housekeeping miRNA.
2.7. Histological analysis of ovarian tissue
One ovary from each animal was fixed in 4% paraformaldehyde, embedded in paraffin, and
serially sectioned (5 μM) at the Iowa State University Veterinary Medicine Histopathology
laboratory. Sections were mounted (3-4 per animal), and one section was stained with
hematoxylin and eosin (H&E). Digital images were acquired with a Leica DMI300B
Fluorescent Microscope.
2.8. Protein Isolation and Immunoblot analysis
Total ovarian protein was isolated and immunoblots performed as previously described 75.
Briefly, ovaries were homogenized in ~ 200 μl of iced-cold extraction buffer containing 50
mM Tris-HCl (pH 8), 150 mM NaCl, 1% NP40 and 1% Protease inhibitor, followed by
centrifugation for 30 minutes at 9300 RCF at 4 °C. Protein concentration was determined
using a standard BCA protocol. Emission absorbance values were detected with a λ = 560
nm excitation on a Synergy™ HT Multi-Detection Microplate Reader using KC4™
software (Bio-TekR Instruments Inc. Winooski, VT). Total protein (20 μg) was separated
using 10% SDS-PAGE and electro-transfer of proteins from the gel to a nitrocellulose
membrane was performed for 60 minutes at 100 V. The membranes were stained with
Ponceau S to visualize the amount of total protein transferred in each lane. To reduce non-
specific binding, membranes were pre-incubated overnight on a rocker at 4°C in a blocking
buffer (5% non-fat dry milk, 5 M NaCl, 20 mM Tris-HCl, 0.15% Tween-20, pH 8).
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Membranes were probed using specific primary antibodies; Rabbit Anti-INSRα (1:500);
Rabbit anti-GSTP (1:200); and mouse Anti-ACTB (1:2000) diluted in 5% non-fat dry milk
in Tris-buffered saline with Tween-20 (TTBS) overnight at 4 °C. Following washing for
three times (10 min each) in TTBS, membranes were incubated at room temperature for 1
hour with HRP-conjugated suitable secondary antibodies (1:2000) against the primary
antibodies. Membranes were washed three times in TTBS followed by a single wash in Tris-
Buffered Saline (TBS). Autoradiograms were visualized on X-ray films in a dark room
following 5 min incubation of membranes in ECLplus chemiluminescence detecting reagent.
Densitometry of the appropriate band was quantified using Image J software (NCBI). Equal
loading was confirmed by Ponceau S staining of membranes and protein expression was
normalized to ACTB densitometry values.
2.9. Immunoflourescence staining
Two slides per animal were deparaffinized in citrol buffer and rehydrated with subsequent
washes in ethanol. Antigen retrieval was carried out by microwaving sections for 7 min in
sodium citrate buffer (1M, pH 6.1). Sections were then blocked in 5% BSA for 1 h at room
temperature. Sections were incubated with a primary antibody directed against pAKTSer473
(1:100) overnight at 4°C. After washing in 1% PBS, sections were incubated with a goat
anti-rabbit secondary antibody conjugated to fluorescein for 1 h. Slides were counterstained
with DAPI nuclear stain for 5 min. Images were taken using a Leica fluorescent microscope.
Analysis of pAKTSer473 protein level in small oocytes (pre-antral follicles), large oocytes
(antral follicles) and theca cells of antral follicles was performed using ImageJ software
(NCBI). Mean densitometry value was divided by the cellular area measured.
2.10. Statistical analysis
Statistical analysis was performed using the unpaired t-test function of GraphPad Prism 5.5
software with a statistical significance level set at P < 0.05. P < 0.1 was considered a trend
for a difference between treatments.
3. Results
3.1. Effect of obesity on ovarian size and weight
There was no impact of HFD on ovarian weight (P > 0.05) ovarian weight (Figure 1A) yet
the ovaries appeared visually smaller relative to their lean littermates (Figure 1B and 1C).
3.2. Effect of obesity on ovarian insulin signaling members
Obesity decreased mRNA level of the gene encoding the Irs1 (P < 0.05) with a trend for a
decrease in Insr (P = 0.08; Figure 2A). Additionally there was a strong trend (P = 0.06) for
decreased INSR protein levels in ovaries of obese female mice compared to lean mice
(Figure 2B and 2C).
3.3. Effect of obesity on ovarian PI3K signaling
Relative to lean ovaries, obesity increased the mRNA levels of Kitlg by 0.6-fold (P < 0.05)
and there was a trend for increased mRNA level of the KITLG receptor, c-Kit of 0.4-fold (P
= 0.07; Figure 3). Obesity also induced a 1.1-fold increase (P < 0.05) in mRNA levels of
Akt1, with a concomitant 0.6-fold decrease (P < 0.05) in mRNA levels of Foxo3a relative to
lean ovaries (Figure 3). pAKTSer473 protein was localized to the oocyte of pre-antral and
antral follicles and also to the theca cells (Figure 4A,B). Obese females had a strong trend (P
= 0.056) for decreased pAKTSer473 protein in the oocytes of pre-antral follicles (Figure 4C),
with no impact observed in the antral follicle oocytes (Figure 4D). Interestingly, there was a
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trend (P = 0.09) for increased pAKTSer473 protein in theca cells from obese females (Figure
4E).
3.4. Effect of obesity on ovarian expressed xenobiotic metabolism genes
There was decreased mRNA level for the gene encoding Cyp2e1 (P < 0.05). In addition a
trend (P < 0.1) for increased Ephx1 and decreased Gstp1 and Gstm1 mRNA levels was
observed (Figure 5A). No impact of obesity on GSTM protein was observed, however, there
was a trend for decreased GSTP protein level (P < 0.1).
3.5. Effect of obesity on ovarian expression of miR-103, miR-21, miR-184 and miR-205
Ovaries from obese mice had decreased (P < 0.05) miR-21, and miR-103 (P < 0.05), with a
strong trend (P = 0.06) for increased miR-205. In contrast, obesity up-regulated (P < 0.05)
miR-184 levels (Figure 6A). The obesity-induced decrease in miR-21 was validated using
qRT-PCR (P < 0.05; Figure 6B).
4. Discussion
Several studies have highlighted a strong correlation between obesity, infertility and adverse
reproductive health outcomes, however, the underlying mechanisms remain unclear [91-95],
thus comprehension of the mechanisms by which obesity affects ovarian function is of
significant relevance. We hypothesized that obesity could alter factors regulating both
primordial follicular activation and xenobiotic biotransformation. The females in this study
were approximately 8.5 months of age, and did not differ in levels of plasma estradiol [90].
Previous studies in humans and rat models have reported that hyperinsulinemia down-
regulates ovarian Insr expression [96, 97]. Similar studies in insulin-resistant and
hyperinsulinemic mice demonstrated altered duration of estrous cycles as well as aberrant
distribution and morphology of ovarian follicles [42, 49, 98]. The metabolic effects of
insulin mainly involve tissue-specific actions which result in changes in gene expression,
protein phosphorylation and function of the INSR and its downstream adaptor proteins,
IRS1-4 [99]. Phosphorylation of IRSs lead to activation of downstream mediators including
the PI3K/AKT serine/threonine kinase [50]. There are several pathological effects associated
with dysregulated PI3K pathway in the ovary. For instance, over activation of PI3K in
oocytes has been associated with premature ovarian failure (POF), while, on the other hand,
over activation of the pathway in granulosa cells is highly correlated with defects in follicle
cyclic recruitment and ovulation and carcinogenesis derived from ovarian surface epithelium
[29-31, 37, 58, 100].
In order to determine the molecular effects of obesity on ovarian function, we first
investigated the effect of obesity on expression of genes encoding the insulin signaling
members, INSR and IRS1, both of which are critical for the response to insulin. Obesity
decreased the mRNA level of Irs1 concomitant with a trend for a reduction in total ovarian
Insr mRNA and protein expression. The effect of obesity on expression of insulin signaling
members in other tissues is well reported but most ovarian studies have reported inconsistent
results. For instance consistent with our findings, reductions in expression of INSR and
IRS1 during obesity [101-103] or hyperinsulinemia [96, 97] have been reported, while in
contrast, increased phosphorylation of both IRS1 and IRS2 with obesity have been also
observed in other cell types [45, 96, 104-107]. Additionally, other studies have observed no
effect of obesity on INSR [3, 42] or IRS1 [3, 108, 109]. Taken together, these results
implicate the effect of obesity on insulin signaling members to be a complex mechanism that
may be species-, tissue- and/or time-specific.
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Following these observations we postulated the insulin-mediated PI3K/AKT pathway could
be compromised. To our surprise our results demonstrated that reduction in mRNA encoding
insulin signaling factors did not inactivate the PI3K/AKT pathway in ovaries of obese mice.
Obese mice had increased Akt1 mRNA levels with a concomitant decrease in Foxo3a
mRNA compared to lean mice. Several other studies show that insulin could have a tissue-
isoform and species specific differential effect on Akt isoforms [53, 110]. In obese rodent
models, insulin-stimulated AKT1 activity was reported to decrease in muscle and adipose
tissue but increased in liver, in contrast, AKT2 activity was decreased in muscle and liver
but increased in adipose tissue [53]. Thus, our data indicate that ovarian AKT1 responds in a
similar fashion to hepatic tissue in the face of changing insulin levels. Whether these
changes are direct interactions between the IRS or involve other signaling mediators is
difficult to surmise from the current data.
Since obesity mildly reduced expression of Insr and Irs1 in mice ovaries while the PI3K
signaling pathway is markedly up-regulated compared to lean mice in our study, we asked
what other insulin-independent pathways involved in activation of the ovarian PI3K/AKT
pathway were altered in the obese mouse ovary. Stem cell growth factor receptor (c-KIT), a
receptor protein tyrosine kinase is expressed by the oocyte [111, 112] and its ligand, Kit
Ligand (KITLG; also called Stem cell factor or Steel factor), is expressed by granulosa cells
[113]. Several lines of evidence have indicated that KITLG/c-KIT signaling is essential for
oocyte viability and survival and that this pro-survival pathway also regulates follicle
recruitment [114-116]. Once c-KIT is bound by KITLG the PI3K pathway is activated
[36-38, 55, 56, 59]. Based on those previous reports and our data we asked if HFD-induced
obesity affected the ovarian mRNA level of genes encoding c-KIT and KITLG. Our data
shows that obesity increased Kitlg mRNA levels with a trend for increased mRNA encoding
its receptor, c-Kit. To the best of our knowledge this is the first study to demonstrate that
HFD-induced obesity can alter the expression of the c-Kit ligand in murine ovaries. In
oocytes of cultured neonatal mouse and rat ovaries, it has been demonstrated that KITLG
leads to phosphorylation of FOXO3a through the action of pAKT [36]. Based on the results
presented herein hyperactivation of KITLG/c-KIT-PI3K/AKT could be a potential
mechanism underlying obesity related infertility problems. It is known that hyperstimulation
of primordial follicles into the growing follicular pool leads to their eventual destruction [55,
57, 59]. Over-activation of the KITLG/c-KIT dependent PI3K/AKT pathway could imply
that in obese female mice, there is over stimulation of primordial follicles into the growing
follicular pool; a scenario that could accelerate the rate at which mice become infertile,
although it should be noted that follicle numbers were not classified in our study.
Interestingly, we also noted a trend for increased theca cell pAKTSer473, and it is known that
the interaction between KITLG and c-KIT has a regulatory role in steroidogenesis in rat
granulosa cells [117].
Several studies have demonstrated that insulin and other growth factors regulate xenobiotic
chemical metabolizing enzyme gene expression, including cytochromes p450, GSTs and
EPHX1 through several kinases including PI3K/AKT signaling pathway [66, 118, 119]. The
ovary has the capacity to metabolize ovotoxic compounds [60, 67, 68, 75, 76, 120-122],
however to date, there is a dearth of literature examining potential effects of obesity on
expression of xenobiotic metabolizing enzymes in the ovary. Since diet-induced obesity can
alter insulin levels and/or sensitivity, we hypothesized that obesity may alter the ovarian
expression of ovotoxicant metabolizing enzymes genes. Previous studies have demonstrated
that diabetes is strongly associated with increased hepatic Cyp2e1 [123] and on the other
hand decreased Ephx1 [124]. Also, Cyp2e1 mRNA expression is decreased in a dose
dependent manner by insulin in rat cultured hepatocytes [123, 125, 126]. PI3K inhibitors
such as wortmannin and LY294002 were shown to reverse the insulin-mediated down-
regulation of Cyp2e1 mRNA levels [127]. Furthermore, in cultured neonatal ovaries,
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inhibition of PI3K signaling using LY294002 resulted in increased mRNA and protein
levels of Ephx1, Gstp and Gstm [67-69]. In the present study decreased mRNA encoding
Cyp2e1 was observed in ovaries of obese mice compared to the lean mice. In contrast to
Cyp2e1, there was a trend for increased Ephx1 mRNA level. This differential effect of a
physiological paradigm on ovarian Cyp2e1 and Ephx1 expression has been previously
reported [76, 128]. Studies on the GSTs have reported both increased and decreased gene
expression during diabetes [66]. In rat cultured hepatocytes, neither insulin nor glucagon
affected the mRNA levels of Gstm while, on the other hand, glucagon reduced Gstp mRNA
levels [129]. In the current study there was a trend for decreased Gstp mRNA and protein
level in the obese ovary. These results suggest that obese females may have altered
xenobiotic metabolism and therefore if such females are exposed to ovotoxicants, the rate at
which they would approach premature ovarian insufficiency and failure would be
accelerated. Further still, these results suggest that obese females may have increased risks
from exposure to carcinogens and teratogens which could also potentially explain the
increased rates of miscarriage and increased offspring birth defects in obese mothers.
PI3K signaling can be regulated through posttranscriptional gene silencing by the action of
miRs [78, 80, 89, 130]. In order to evaluate if obesity had any effect on miR’s that could at
least partially explain the effects observed on PI3K signaling, levels of miR-103, miR-21,
miR-184 and miR-205 were measured. It was found that the ovaries from obese mice had
decreased miR-21 and miR-103; however, miR-184 levels were increased. Recent reports
have indicated that miR-21 expression is important for regulation of apoptosis [131, 132].
Decreased expression of miR-21 expression has been reported to increase cell apoptosis in a
variety of cell culture systems including the granulosa cells from mouse pre-ovulatory
follicles both in vivo and in vitro [86]. In addition, miR-21 has been identified as promoting
follicular cell survival during ovulation and miR-21 inhibition also has been reported to
reduce ovulatory rates [86]. Although many different cell types undergo apoptosis in
response to inhibition of miR-21 action, the miR-21 targets implicated vary widely for
different cells and the mechanism by which miR-21 suppresses apoptosis in GCs remain to
be identified [133-135].
miR-184 has been shown to act as a physiological suppressor of general secretory activity of
progesterone and estradiol [135, 136]. Additionally, miR-184 is believed to play a critical
role in development as well as being a mediator of apoptosis. Up-regulation of miR-184 has
been reported to interfere with the ability of miR-205 to lead to repression of AKT signaling
[78]. Though in this study we observed an elevated level of miR-184 with a trend for a
decrease in miR-205 level, there was an up-regulation of Akt1 mRNA levels together with a
subsequent decrease in Foxo3a mRNA levels thus indicating that Akt1 activation is not
being compromised by miR-205 action. Several studies from both human and rodent models
have reported that miR-103 is up-regulated during obesity [89, 137, 138]. It has been further
suggested that silencing miR-103 improves insulin sensitivity in adipocytes mainly through
increased caveolin-1 expression, which in turn leads to stabilization of the INSR and thus
enhancing insulin signaling [89]. In contrast to the above reports miR-103 expression has
also been found to be down-regulated in the mouse model of genetic insulin resistance and
obesity (ob/ob mice) [139]. This is consistent with our findings, where obesity decreased
miR-103 levels in mice ovaries. These results further confirm miRNA cell and tissue
specific actions [140].
5. Conclusions
In summary, the data presented herein, though preliminary in nature, demonstrate
perturbations to ovarian PI3K signaling caused by obesity in females. Under basal
conditions, AKT1 is positively regulated by both KITLG and IRS1. In addition, AKT1 is
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positively regulated by miR21 and negatively regulated by miR184. Our data collectively
indicates that obesity decreases IRS1 levels but increases KITLG which can then result in
increased AKT1 levels. Although miR21 is decreased, which should result in decreased
AKT1, we propose that increased levels of miR184 may counteract decreased miR21 to
result in AKT1 activation (summarized in Figure 7). One consequence of obesity-induced
altered PI3K includes changes in the downstream components Akt1 and Foxo3a that may
alter the rate of primordial follicle activation, leading to fertility problems. Another result of
altered PI3K observed is that expression of major xenobiotic biotransformation enzymes that
are important in the ovarian response to ovotoxicant exposure, are changed. Thus, obesity
may have negative consequences for follicle activation and oocyte viability, as well as
altering how the ovary responds to chemical exposures. All of these scenarios can lead to
impairment of ovarian function, and may at least partially explain why reproduction is
compromised in obese females.
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Highlights
High fat feeding increased phosphatidylinositol-3 kinase signaling
Obese mice had altered xenobiotic metabolism gene expression
Obesity induced altered microRNA expression
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Figure 1. Obesity does not alter ovarian weight in mice
Six weeks old C57Bl/6J female mice (n = 6 per treatment group) were fed either a standard
chow mice diet or a high-fat diet for approximately 7 months and were euthanized by CO2
asphyxiation. Ovaries were removed, trimmed of excess fat and weighed. (A) Ovarian
weight; (B) lean and (C) obese ovarian sections stained with hematoxylin and eosin (H&E).
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Figure 2. Obesity decreases ovarian Irs1 mRNA levels in mice
Ovaries were removed from lean and obese mice (n = 6 per treatment group). (A) RNA was
isolated and Insr and Irs1 mRNA levels were evaluated by quantitative RT-PCR. Values
represent fold-change relative to a control value of 1 ± SE, normalized to Actb. (B) Total
protein was isolated and Western blotting performed to measure INSR level. Values
represent fold-change relative to a control value of 1 ± SE, normalized to ACTB. Different
from control, *P < 0.05. (C) Representative Western blot for INSR and ACTB; Lean = L,
Obese = O.
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Figure 3. Obesity enhances ovarian KITLG/KIT-PI3K/AKT1 signaling pathway in mice
Ovaries were removed from lean and obese mice (n = 6 per treatment group). RNA was
isolated and Kitlg, cKit, Akt1 and Foxo3a mRNA levels were evaluated by quantitative RT-
PCR. Values represent fold-change relative to a control value of 1 ± SE, normalized to Actb.
Different from control, *P < 0.05.
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Figure 4. Altered pAKTSer473 levels are observed in the ovaries of obese mice
Ovaries were removed from (A) lean and (B) obese mice, serially sectioned and mounted
onto slides (n = 6 per treatment group). Immunoflourescence staining to detect pAKTSer473
was performed, with counterstaining to detect the nucleus. Image J software was used to
quantify levels of pAKTSer473 in (C) small (pre-antral; indicated by arrowhead) and (D)
large oocytes (antral; indicated by broken arrow) and (E) theca cells (indicated by unbroken
arrow).
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Figure 5. Obesity down-regulates ovarian Cyp2e1 mRNA levels
Ovaries were removed from lean and obese mice and RNA isolated (n = 6 per treatment
group). (A) Cyp2e1, Ephx1, Gstp and Gstm mRNA levels were measured by quantitative
RT-PCR. Values represent fold-change relative to a control value of 1 ± SE, normalized to
Actb. Different from control, *P < 0.05. (B) Western blotting was performed to determine
any impact of obesity on GSTP. (C) Representative Western blot for GSTP and ACTB;
Lean = L, Obese = O.
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Figure 6. Obesity alters levels of ovarian miR
Ovaries were removed from lean and obese mice and RNA isolated (n = 3 per treatment
group). (A) Enriched miR fractions were analyzed using a miR array. (B) qRT-PCR was
performed on miR-21 to confirm the array data. Values represent fold-change relative to a
control value of 1 ± SE, normalized to RAU43. Different from control, *P < 0.05.
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Figure 7. Proposed model of obesity effects on AKT1 signalinga
Under basal conditions, AKT1 is positively regulated by both KITLG and IRS1. In addition,
AKT1 is positively regulated by miR21 and negatively regulated by miR184. Our data
indicates that obesity decreases IRS1 levels but increases KITLG leading to increased AKT1
levels. The increased levels of miR184 may counteract the decreased miR21 in AKT1
activation. AKT regulates xenobiotic metabolism, primordial follicle activation and viability
as well as ovarian steroidogenesis. Thin arrows indicate positive regulation, negative
regulation is indicated by the broken arrow. Block arrows indicate the impact of obesity.
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Table 1
Sequences of primers used
Primer name Sequence
Insr-for ATGGGCTTCGGGAGAGGAT
Insr-rev GGATGTCCATACCAGGGCAC
Irsl-for GGATGTCCATACCAGGGCAC
Irsl-rev CAGCCCGCTTGTTGATGTTG
Cyp2e1-for CCCAAGTCTTTAACCAAGTTGGC
Cyp2e1-rev CTTCCATGTGGGTCCATTATTGA
c-kit-for GCCACGTCTCAGCCATCTG
c-kit-rev GTCGGGATCAATGCACGTCA
Kitlg-for GAATCTCCGAAGAGGCCAGAA
Kitlg-rev GCTGCAACAGGGGGTAACAT
Akt1-for CCACCTGTCTCTAGGGTCCA
Akt1-rev CATGGGACACAGCAACAAAC
Gstp-for CCCAAGTTTGAGGATGGAGA
Gstp-rev CAGGGCCTTCACGTAGTCAT
Gstm-for GAGAGGATCCGTGCAGACAT
Gstm-rev ACTTGGGCTCAAACATACGG
Foxo3a-for GGTACCAGGCTGAAGGATCA
Foxo3a-rev CAGTCTCTGCTGGGTTAGGG
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